Administered By

• Duke Clinical Research Institute

Awarded By

• AstraZeneca Pharmaceuticals, LP 

Contributors

• Harrison, Michael Roger Co Investigator
• Scales Jr., Charles Douglas Principal Investigator

Start/End

• September 8, 2016 - December 31, 2017